Pseudomonas Aeruginosa Infection Market is driven by market growth
The Pseudomonas Aeruginosa Infection Market centers on advanced antibacterial therapies designed to combat infections caused by P. aeruginosa, a gram-negative pathogen notorious for its drug-resistance and biofilm formation. Products in this market include novel antibiotics, combination therapies and inhaled formulations that offer targeted delivery, reduced systemic toxicity and improved...
0 Comments 0 Shares 47 Views 0 Reviews